Bone and soft tissue cancers How we treat bone and soft tissue cancers The medical team at the Institut Jules Bordet treats tumours that appear in the soft tissue (muscles, fat, nerves, blood vessels, etc), primary bone cancer in children (in close collaboration with HUDERF – the Hôpital Universitaire des Enfants Reine Fabiola) and in adults as well as bone metastases. ...
Liver cancers “A surgeon never takes the decision to operate on their own. The management of hepatic tumours is always multidisciplinary.” Dr Vincent Donckier, Hepatobiliary surgeon and head of surgery, Institut Bordet. How we treat liver cancers There are 2 types of hepatic cancer: primary liver cancer and hepatic metastases originating from other primary tumours. Surgery is the major treatment for these cancers but it is limited by the need to conserve sufficient functional liver tissue. Other therapies may be combined with surgery. ...
Brain tumours « Neuro-Oncology is above all a multidisciplinary approach at the centre of which the quality of life of the patient is crucial » Dr Philippe Martinive Clinic Director How we treat brain tumours The Institut Jules Bordet treats both primary brain cancers and brain metastases. Medical imaging plays a major role in this treatment because, in the brain, accurate definition of the tumour is crucial. ...
Neuroendocrine tumours “A neuroendocrine tumour is a particular kind of digestive cancer that requires very specific management.” Pr. Jean-Luc Van Laethem Digestive Oncology, Clinic Head How we treat neuroendocrine tumours Although often situated in an organ of the digestive tract, neuroendocrine tumours behave differently from other digestive cancers and must often be treated in a specific way. ...
Hematology department Our role The Clinical Haematology Department at the Jules Bordet Institute specialises in determining and treating malignant haemopathies (blood cancers). The Jules Bordet Institute is committed to treating these diseases with the aim of providing the patient with individualised care of the highest quality in terms of treatment and support.In addition to treating malignan...
Anaesthesiology and Intensive Care Department Our role The anaesthetist’s work is often little known but it is fundamental for optimal and safe patient care. Indeed, before anything else, it is the anaesthetist who evaluates the patient’s state of health before, during and after the operation, the surgeon essentially taking care of the intervention. Before the operation: the first evaluation i...
Surgery department Our rol The principal mission of the Institut Bordet Department of Surgery is the surgical treatment of cancerous diseases. More specifically, our surgeons strive to: offer leading-edge surgical techniques in the treatment of cancer; integrate surgery into global cancer treatment; encourage approaches combining surgery and other treatments such as chemotherapy, radiotherapy,...
Oncological day hospital Our role The aim of the oncology day hospital (a care platform) is to avoid hospitalisation with night stays while limiting the impact of the disease and its treatments on the personal, family, social and professional life of patients with cancer. The following may be carried out in the Day Hospital: Conventional anti-cancer treatments (chemotherap...
Nuclear Medicine Our role The nuclear medicine department of the Institut Jules Bordet offers patients diagnostic tests of the functional or molecular type, as well as treatments with targeted molecular radiotherapy. The diagnostic tests differ from those carried out in the Radiology Department in that they involve the intravenous administration of substances labelled with radioactive isotope...
Radiotherapy Our role Radiotherapy is one of the main treatments for cancer and is used as an independent treatment or in combination with surgery and/or systemic treatment (i.e. chemotherapy). The goal is to cure cancer, to augment the prognosis, or to palliate symptoms.Radiation therapy has a biological effect on the DNA and the inflammatory status of the tumor. The side effects are decrease...
Nursing department Our rol The mission of the Institut Bordet Department of Nursing is to provide comprehensive care for patients affected by cancer and to deliver high-quality, adapted and personalised nursing care as part of a multidisciplinary team. The Department also seeks to promote the skills, motivation and empowerment of its nursing staff and carers.Nursing care is delivered according...
Molecular Immunology Laboratory (MIU) Overview The Molecular Immunology Laboratory strives to improve our understanding of the immune response in cancer and how it can be manipulated to the benefit of the patients. It investigates lymphocyte activities in several clinical conditions: First, by studying the organization and cellular state of CD4+ T cells and germinal center B cells infiltratin...
Contractual support for promotion and investigation (Clinical Trials Center - CTC) Our role Investigation means contract support to clinical studies sponsorship and participating site...
Clinical Trials Center (CTC) - Promotion operation support (CTSU) Our role Promotion means operations support to clinical studies sponsorship activities.CTC is a support service, taking into account aspects of commercial and academic clinical research, with the mission of providing professional assistance to clinical research by centralizing and harmonizing the administrative, operational (eg:...
A new building for the Institut Jules Bordet Since the end of November 2021, the Jules Bordet Institute is located on the ULB campus in Anderlecht! The new Institut Jules Bordet, a building for the practice of medical excellence now and in the future. Videos ...
Professional access Mail hubruxelles.beMail bordet.be PSOM ...
Skin cancers “The quality of life of our patients is at the centre of our multidisciplinary care” Prof. Annie Drowart, Coordinator of the “skin” COM of the Institut Jules Bordet. How we treat skin cancers The Institut Jules Bordet treats all skin cancers: melanomas, spinocellular carcinomas, basocellular carcinomas, Merkel cell carcinomas, etc. ...
Clinical Cellular Therapy Research Laboratory (LTCC) Description The Institut Bordet Clinical Cellular Therapy Research Laboratory (LTCC) is dedicated to fundamental and translational research in the fields of haematology and immunology cellular therapy. The LTCC’s main objectives concern: study of the interaction between leukaemic cells and their microenvironment; establishment of new prognos...
History of the Institut Jules Bordet Jules Bordet, a pioneer in cancer research Since it was founded in 1939, the Institut Bordet has always remained loyal to its pioneering role in the fight against cancer. With this complex disease, the lives of patients and caregivers do more than simply cross paths, they become entwined. Here are some of the key dates in the history of the Institut Bordet – an institution that is proud of its past but which always looks resolutely towards the future. Creation of the Institut Jules BordetToday, the Institut Bordet remains Belgium’s only integrated, monospecialist cancer hospital. The European Organisation for Research and Treatment of Cancer (EORTC) is established by Professor TagnonToday, the EORTC includes around 300 institutions which work together to develop the best possible th...
Movember 2024 : In November Bordet is pulling out all the stops ! Throughout the month of November our teams will be mobilising to put the spotlight on combatting male cancers and making men more aware of the need to look after their health : ...